Seel, a poster on IHUB in the medical industry and a very good poster IMO says the current treatment for RB has a 93% 5 yr survival rate. If this is the case, would Kevetrin still be needed as maybe it could totally cure the cancer and allow for even longer than 5 yr survival or would the test do more for CTIX in establishing it's efficacy and safety in infants rather than bringing a whole new level of RB treatment to the few patients having the RB condition?
I was stunned to know there was currently a very high success treatment available but happy to know these kids did have a current source of hope for the problem.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links